Olon

Olon Group is a global leader in developing and producing active pharmaceutical ingredients (APIs) for CDMO and generic markets. We integrate chemical synthesis and biological processes and adhere to the highest international safety, quality, and environmental standards. With an extensive API industry track record, deep development expertise, and advanced technologies, we excel as the preferred partner for successfully launching clients" molecules into the market. Olon operates eleven manufacturing sites and seven R&D centers worldwide, supported by 2,300 employees, including 300 skilled R&D experts. We prioritize innovation and reliability, offering expertise and flexible solutions in custom chemical synthesis and microbial fermentation. Our commitment remains steadfast in delivering outcomes that meet stringent safety, quality, and environmental regulations.